UPDATE (Jan 20 2012): A second decision further reinforces the recommendation.

Brigitte Alfter posts to the Wobbing EU mailing list about the EU Ombudsman’s recommendation that the European Medicines Agency disclose documents on adverse reactions to a particular medicine. Continue reading →